Sponsored by: Investment Center

Something new in your business?  Click here to submit your business press release

Chamber Corner | Main Street News | Job Hunt | Classifieds | Calendar | Illinois Lottery 

Actavis in talks to buy Allergan for at least $60 billion: Bloomberg

[November 12, 2014]  (Reuters) - Actavis Plc is in talks to buy Allergan Inc <AGN.N> for at least $60 billion in a deal that could culminate this month, Bloomberg reported, citing sources familiar with the matter.

The two companies are trying to narrow a gap of about $3 billion between what Actavis wants to pay and what Allergan is asking for, Bloomberg reported. (http://bloom.bg/1ubCVL6)

Allergan, which is trying to fend off a hostile takeover bid from Canadian drugmaker Valeant Pharmaceuticals International Inc <VRX.TO>, on Wednesday changed its bylaws associated with calling a special shareholder meeting.

(Reporting by Natalie Grover in Bangalore; Editing by Saumyadeb Chakrabarty)

[© 2014 Thomson Reuters. All rights reserved.]

Copyright 2014 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.